Global Atherectomy Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The Global Atherectomy Devices Market is segmented by product, with key categories including mechanical atherectomy devices, laser atherectomy devices, rotational atherectomy devices, and orbital atherectomy devices. Mechanical atherectomy devices are used to remove plaque from the arteries by using a rotating blade or cutter. These devices are commonly used in peripheral artery disease (PAD) and coronary artery disease (CAD) treatments. Laser atherectomy devices utilize laser energy to vaporize and remove plaque, often used for smaller or more complex blockages in vessels. Rotational atherectomy devices are designed to rotate at high speeds to shave off hardened plaque, helping restore blood flow in narrowed arteries. Orbital atherectomy devices work by using an oscillating motion to break up plaque and improve blood vessel patency. The continued advancement of these technologies, with improvements in precision and safety, is a key factor driving the growth of the atherectomy devices market.

The application segment of the atherectomy devices market includes key areas such as coronary artery disease, peripheral artery disease, and other vascular diseases. Coronary artery disease (CAD) is one of the leading causes of heart attacks, and atherectomy devices are used to remove blockages in coronary arteries, enabling improved blood flow and reducing the risk of further complications. Peripheral artery disease (PAD) involves the narrowing of arteries in the legs and is a common application for atherectomy devices, helping restore blood flow and alleviate symptoms like pain and numbness in the limbs. These applications are critical in the growing global focus on treating vascular diseases and managing the aging population, which is increasingly at risk for cardiovascular and peripheral artery diseases.

The end-user segment of the market includes hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals are the largest end-user segment, as they offer a broad range of cardiovascular and peripheral vascular procedures, including atherectomy treatments for patients with arterial blockages. Ambulatory surgical centers (ASCs) are gaining traction due to the preference for outpatient procedures, which allow patients to undergo treatments and return home the same day. Specialty clinics, focusing on vascular care, also contribute to the market by providing specialized services for patients with vascular diseases. Geographically, North America holds a dominant share of the atherectomy devices market, driven by advanced healthcare infrastructure, high adoption of cutting-edge medical devices, and a growing aging population. Meanwhile, the Asia-Pacific region is expected to see substantial growth due to the increasing prevalence of vascular diseases, expanding healthcare access, and rising awareness about advanced medical treatments. The overall market is anticipated to continue expanding as atherectomy devices evolve and become more widely available across global healthcare systems.

Global Atherectomy Devices Segment Analysis

In this report, the Global Atherectomy Devices Market has been segmented by Product, Application, End Users, and Geography.

Global Atherectomy Devices Market, Segmentation by Product

The Global Atherectomy Devices Market has been segmented by Product into Directional Atherectomy Systems, Orbital Atherectomy Systems, Photo-Ablative (Laser) Atherectomy Systems, and Rotational Atherectomy Systems.

Directional atherectomy systems represent one primary product category within this market, utilizing cutting blades or drills to excise and remove plaque in a controlled manner. These systems offer precise lesion targeting and tissue removal capabilities, enabling the treatment of complex lesions and calcified plaque in peripheral and coronary arteries.

Orbital atherectomy systems constitute another significant product segment in the atherectomy devices market, featuring a unique orbital motion to debulk and modify calcified plaque without causing vascular injury. These systems employ a crown-shaped abrasive surface that rotates eccentrically within the artery, shaving off plaque layers and creating a smoother vessel lumen for improved blood flow. Orbital atherectomy systems offer versatility and efficacy in treating severely calcified lesions and challenging vascular anatomy, particularly in peripheral artery disease (PAD) and coronary artery disease (CAD) interventions.

Photo-ablative (laser) atherectomy systems utilize focused laser energy to vaporize and ablate atherosclerotic plaque, enabling precise tissue removal and vessel lumen enlargement. These systems deliver controlled thermal energy to target lesions, vaporizing plaque components such as calcium, lipid, and fibrous tissue while minimizing thermal damage to adjacent tissues. Laser atherectomy systems offer flexibility and versatility in treating various lesion morphologies and locations, including heavily calcified or fibrotic lesions that may be difficult to treat with other atherectomy modalities.

Rotational atherectomy systems round out the product segmentation in the atherectomy devices market, employing high-speed rotational burrs or blades to ablate and remove calcified plaque from arterial walls. These systems utilize rotational motion to pulverize plaque components, creating a smooth vessel lumen and restoring blood flow in occluded or stenotic arteries. Rotational atherectomy systems offer precision, control, and efficacy in treating calcified lesions, particularly in complex anatomies and heavily calcified vessels encountered in PAD and CAD interventions.

Global Atherectomy Devices Market, Segmentation by Application

The Global Atherectomy Devices Market has been segmented by Application into Peripheral Vascular Applications, Cardiovascular Applications, and Neurovascular Applications.

Peripheral vascular applications represent a significant segment within this market, encompassing interventions performed in arteries outside the heart, including the lower extremities (e.g., femoral, iliac, popliteal, tibial arteries) affected by peripheral artery disease (PAD). Atherectomy procedures in peripheral vascular applications aim to remove atherosclerotic plaque, restore blood flow, and alleviate symptoms such as claudication, ischemic rest pain, and tissue loss in patients with PAD.

Cardiovascular applications constitute another important segment in the atherectomy devices market, focusing on interventions performed in the coronary arteries that supply blood to the heart muscle. These interventions are indicated for the management of coronary artery disease (CAD), including stable angina, unstable angina, acute myocardial infarction, and ischemic heart disease. Atherectomy procedures in cardiovascular applications aim to optimize myocardial perfusion, relieve anginal symptoms, and reduce the risk of adverse cardiovascular events such as myocardial infarction or sudden cardiac death.

Neurovascular applications represent a specialized segment within the atherectomy devices market, involving interventions performed in the cerebral arteries supplying blood to the brain. These interventions are indicated for the management of cerebrovascular diseases such as ischemic stroke, transient ischemic attack (TIA), intracranial atherosclerosis, and cerebral aneurysms. Atherectomy procedures in neurovascular applications aim to remove obstructive plaque, restore cerebral blood flow, and prevent or mitigate neurological deficits associated with acute or chronic cerebrovascular ischemia.

Global Atherectomy Devices Market, Segmentation by End Users

The Global Atherectomy Devices Market has been segmented by End Users into Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others.

Hospitals and surgical centers represent the primary end-user segment within this market, encompassing a broad spectrum of healthcare facilities, including tertiary care hospitals, academic medical centers, and specialty surgical centers. These facilities offer comprehensive cardiovascular services, including diagnostic imaging, interventional procedures, and surgical interventions for patients with peripheral artery disease (PAD), coronary artery disease (CAD), and other vascular disorders requiring atherectomy treatments.

Ambulatory care centers constitute another significant end-user segment in the atherectomy devices market, providing outpatient medical services, including diagnostic testing, minimally invasive procedures, and postoperative care for patients with vascular diseases. These centers offer a convenient and cost-effective alternative to hospital-based care, allowing patients to undergo atherectomy procedures in a comfortable, outpatient setting with reduced waiting times and shorter recovery periods. Ambulatory care centers may specialize in cardiovascular care, interventional radiology, or vascular surgery, offering a range of atherectomy treatments for patients with peripheral vascular, cardiovascular, and neurovascular diseases.

Research laboratories and academic institutes represent key contributors to the atherectomy devices market, conducting basic and translational research to advance our understanding of atherosclerotic vascular disease, develop innovative treatment strategies, and evaluate the efficacy and safety of atherectomy devices and procedures. These institutions utilize preclinical models, clinical trials, and multidisciplinary research collaborations to explore new therapeutic targets, optimize device design, and improve patient outcomes in the management of vascular disorders. Research laboratories and academic institutes play a vital role in training the next generation of healthcare professionals, fostering innovation, and driving advancements in vascular medicine and interventional cardiology.

Global Atherectomy Devices Market, Segmentation by Geography

In this report, the Global Atherectomy Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Atherectomy Devices Market Share (%), by Geographical Region, 2024

North America typically commands a significant portion of the market share, driven by well-established healthcare systems, high incidence of cardiovascular diseases, and advanced interventional cardiology practices. The United States, in particular, contributes substantially to the North American market share due to its large population, aging demographics, and robust investment in cardiovascular care and medical technologies.

Europe represents another major market for atherectomy devices, characterized by diverse healthcare systems, regulatory frameworks, and patient demographics across different countries. Countries such as Germany, the United Kingdom, and France are significant contributors to the European market share, supported by robust reimbursement policies, clinical research infrastructure, and physician training programs in interventional cardiology. Despite economic challenges and healthcare budget constraints in certain regions, Europe maintains a considerable market share in atherectomy devices, driven by its commitment to cardiovascular health and technological innovation.

Asia-Pacific, Latin America, and the Middle East & Africa are witnessing rapid growth in the atherectomy devices market, fueled by increasing healthcare expenditures, rising prevalence of cardiovascular risk factors, and improving access to advanced medical technologies. Countries such as China, India, Brazil, and South Africa are experiencing a surge in cardiovascular diseases, driven by lifestyle changes, urbanization, and population aging. Moreover, collaborations between multinational medical device companies and local healthcare providers are facilitating technology transfer, capacity building, and market penetration in these regions, driving continued growth and innovation in the global atherectomy devices market.

This report provides an in depth analysis of various factors that impact the dynamics of Global Atherectomy Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Increasing Prevalence of Peripheral Artery Disease
• Technological Advancements in Atherectomy Devices
• Growing Aging Population

• Rising Demand for Minimally Invasive Procedures - The rising demand for minimally invasive procedures, including atherectomy, reflects a broader trend in healthcare towards treatments that offer less trauma, faster recovery times, and reduced risk of complications compared to traditional open surgeries. Minimally invasive procedures involve smaller incisions, specialized instruments, and advanced imaging technologies, allowing healthcare providers to perform complex interventions with greater precision and efficiency.

  Advancements in medical technology, including the development of innovative devices and imaging modalities, have expanded the range of conditions that can be treated using minimally invasive techniques. Atherectomy devices, for example, have evolved to become more precise, efficient, and versatile, allowing healthcare providers to safely remove plaque buildup from diseased arteries while preserving vessel integrity. This technological progress has fueled the adoption of minimally invasive procedures for the management of PAD and other vascular conditions.

  The healthcare industry is increasingly embracing minimally invasive procedures as a means to enhance patient care, optimize resource utilization, and improve cost-effectiveness. Minimally invasive techniques are associated with shorter hospital stays, reduced need for post-operative care, and lower rates of complications, resulting in cost savings for healthcare systems and payers. Additionally, as healthcare reimbursement models shift towards value-based care and bundled payments, there is growing recognition of the benefits of minimally invasive procedures in improving patient outcomes and reducing healthcare costs.

Restraints

• High Cost of Atherectomy Procedures
• Reimbursement Challenges
• Limited Awareness and Access in Developing Regions

• Regulatory Hurdles and Compliance Issues - Regulatory hurdles and compliance issues pose significant challenges to the atherectomy devices market, impacting product development, market access, and commercialization strategies. Regulatory agencies, such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, impose stringent requirements for the approval and marketing of medical devices, including atherectomy devices, to ensure patient safety and product efficacy.

  Regulatory compliance issues, such as product recalls, quality control deficiencies, and non-compliance with regulatory requirements, can have serious consequences for atherectomy device manufacturers, including reputational damage, financial penalties, and legal liabilities. Regulatory agencies conduct inspections and audits of manufacturing facilities and quality management systems to ensure compliance with Good Manufacturing Practices (GMP) and other regulatory standards. Failure to address compliance issues promptly and effectively can result in enforcement actions, product recalls, and market withdrawal, jeopardizing market access and revenue streams for manufacturers.

  Regulatory hurdles and compliance issues can impact market competitiveness and innovation within the atherectomy devices market. Smaller companies and startups may face greater challenges in navigating regulatory pathways and achieving regulatory approval for their products, limiting their ability to compete with larger, established manufacturers. Additionally, regulatory requirements may impose constraints on product design, development, and customization, inhibiting innovation and technological advancements in atherectomy device technology.

Opportunities

• Development of Next-Generation Atherectomy Technologies
• Emerging Markets Expansion
• Focus on Value-Based Healthcare Models

• Increasing Adoption of Drug-Coated Atherectomy Devices - The increasing adoption of drug-coated atherectomy devices represents a significant advancement in the treatment of peripheral artery disease (PAD), offering a targeted approach to plaque removal while simultaneously delivering therapeutic agents to prevent restenosis and improve long-term outcomes for patients. Drug-coated atherectomy devices combine the mechanical action of atherectomy with the localized delivery of antiproliferative or antithrombotic drugs, addressing both the underlying disease pathology and the risk of recurrent narrowing or occlusion of the treated vessel.

  Drug-coated atherectomy devices offer several advantages over other treatment modalities for PAD, including drug-coated balloons and drug-eluting stents. Unlike drug-coated balloons, which rely on balloon inflation to deliver drugs to the vessel wall, drug-coated atherectomy devices provide mechanical plaque removal and drug delivery in a single step, offering more precise and controlled drug distribution. Additionally, compared to drug-eluting stents, which can pose challenges in treating heavily calcified lesions or bifurcation lesions, drug-coated atherectomy devices provide a more flexible and adaptable treatment option, allowing for optimal plaque debulking and vessel preparation.

  The increasing adoption of drug-coated atherectomy devices is supported by a growing body of clinical evidence demonstrating their safety, efficacy, and cost-effectiveness in the management of PAD. Clinical studies and real-world registries have shown that drug-coated atherectomy devices can achieve excellent procedural success rates, favorable clinical outcomes, and durable patency in patients with complex arterial lesions. Additionally, health economic analyses have demonstrated the potential for cost savings and improved resource utilization with the use of drug-coated atherectomy devices compared to alternative treatment strategies, further supporting their widespread adoption in clinical practice.

Key players in Global Atherectomy Devices Market include :

• Abbott
• Avinger
• B. Braun Group
• Biomerics
• Biotronik
• Boston Scientific
• C.R. Bard
• Cardinal Health
• Cardiovascular Systems

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis